Last updated: April 23, 2024
Sponsor: Wright State University
Overall Status: Active - Recruiting
Phase
1
Condition
Squamous Cell Carcinoma
Sun Poisoning
Warts
Treatment
Vehicle
Imipramine
Clinical Study ID
NCT05688904
07286
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Male or female ages 18 and older
- Skin type must be "Fair", Fitzpatrick type I to III, due to the presence of actinicdamage in this population.
- Subjects need to have a physician's order to receive PDT treatment on their face,scalp or forearms.
- Willing to participate and understand the informed consent document.
- Willing to avoid excess sun exposure/tanning beds to the area to be treated with PDT.
Exclusion
Exclusion Criteria:
- Those currently taking any tricyclic antidepressants (TCAs)
- Those currently taking any selective serotonin reuptake inhibitor (SSRI)
- Those with porphyria
- Large tattoos in the treated areas
- Pregnancy or nursing
- Taking any oral or topical medications that could interfere with the PDT (Appendix A)
- Active rashes in the area
Study Design
Total Participants: 24
Treatment Group(s): 2
Primary Treatment: Vehicle
Phase: 1
Study Start date:
January 19, 2023
Estimated Completion Date:
March 31, 2028
Connect with a study center
Wright State Physicians
Fairborn, Ohio 45324
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.